Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.
Published April 7, 2021 · Recall initiated: February 18, 2021
Summary
FDA records drug Class I recall D-0315-2021, published April 7, 2021 and initiated February 18, 2021. Recalling firm: Zydus Pharmaceuticals (USA) Inc; Status: Terminated; Reported quantity: 816 packs; Lot: Lot#: L000155, Exp 12/2021; L000156, Exp 1/2022. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Crystallization: customer complaints for crystallization in finished product.
What to do
Voluntary: Firm initiated · Letter
Get an email if ACYCLOVIR has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ACYCLOVIR
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc
- Distributor
- USA Nationwide
- Lot
- Lot#: L000155, Exp 12/2021; L000156, Exp 1/2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAcyclovir Tablets, USP, 400 mg, 100 Tablets, Rx Only, Distributed by: Avet Pharmaceuticals Inc., EastMay 12, 2021
- FDATremfya (guselkumab) Injection, 100 mg/mL, one single-dose prefilled syringe per carton, Rx only, ManufacturedApril 7, 2021
- FDAZOMA-Jet 5 Demonstration Kit, Needle-free delivery device for use with ZOMACTON (somatropin) for injection 5mgApril 7, 2021
- FDAAcyclovir Tablets, USP, 400 mg, 100 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., IndiaMay 15, 2019
- FDAAcyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDCMarch 7, 2018
- FDAAcyclovir Tablets, USP, 800 mg, 100-count bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc.,June 14, 2017
Questions about this recall
Was Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India. Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. recalled?
Yes. FDA published recall D-0315-2021 on April 7, 2021. Reported hazard: Crystallization: customer complaints for crystallization in finished product.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ACYCLOVIR.